Page last updated: 2024-10-27

fluorouracil and Hemoglobinuria, Paroxysmal

fluorouracil has been researched along with Hemoglobinuria, Paroxysmal in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Hemoglobinuria, Paroxysmal: A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, M1
Chase, J1
Brinkmeier, M1
Xu, J1
Weinberg, DN1
Schira, J1
Friedman, A1
Malek, S1
Grembecka, J1
Cierpicki, T1
Dou, Y1
Camper, SA1
Maillard, I1

Other Studies

1 other study available for fluorouracil and Hemoglobinuria, Paroxysmal

ArticleYear
Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.
    The Journal of clinical investigation, 2015, Volume: 125, Issue:5

    Topics: Anemia, Aplastic; Animals; Animals, Newborn; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bo

2015